Skip to main content
Clinical Trials/NCT02081209
NCT02081209
Completed
Not Applicable

Non-Invasive Fat Layer Reduction in the Lateral Thighs With a Cryolipolysis System Using Varied Treatment Parameters

Zeltiq Aesthetics2 sites in 1 country40 target enrollmentFebruary 4, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Body Fat Disorder
Sponsor
Zeltiq Aesthetics
Enrollment
40
Locations
2
Primary Endpoint
Safety of the Zeltiq Device
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

The purpose of this study is to compare the performance of the Zeltiq CoolSculpting System using various treatment parameters for non-invasive reduction of subcutaneous fat in the lateral thighs.

Detailed Description

The purpose of this study is to compare the performance of a cryolipolysis system using various treatment parameters for non-invasive reduction of subcutaneous fat in the lateral thighs.

Registry
clinicaltrials.gov
Start Date
February 4, 2014
End Date
October 21, 2014
Last Updated
11 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Zeltiq Aesthetics
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Safety of the Zeltiq Device

Time Frame: From enrollment through 16 week follow-up (approximately 5 months)

The number of unanticipated adverse device effects (UADEs) will be tabulated.

Percentage of Pre-treatment Images Correctly Identified.

Time Frame: Baseline and 16 weeks post-treatment

Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure. The expected success rate is 80%.

Secondary Outcomes

  • Change in the Fat Layer of the Treated Area as Measured by Ultrasound(16 weeks post-treatment)
  • Subject Satisfaction(16-weeks post treatment)

Study Sites (2)

Loading locations...

Similar Trials